Functional and physical interactions between the Epstein-Barr virus (EBV) proteins BZLF1 and BMRF1: Effects on EBV transcription and lytic replication

Journal of Virology

Volumn 70, Issue 8, 1996, Pages 5131-5142

  Zhang, Qin ^a   Hong, Yu ^a   Dorsky, David ^b   Holley Guthrie, Elizabeth ^a   Zalani, Sunita ^a   Elshiekh, Nina Aly ^a   Kiehl, Anita ^b   Le, Trung ^b   Kenney, Shannon ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; MUTANT PROTEIN; VIRUS PROTEIN;

ARTICLE; EPSTEIN BARR VIRUS; HELA CELL; HUMAN; HUMAN CELL; LYSIS; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; VIRAL GENETICS; VIRUS GENOME; VIRUS REPLICATION; VIRUS TRANSCRIPTION;

EID: 0029931715     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.8.5131-5142.1996     Document Type: Article

References (76)

1. Baer, R., A. Bankier, M. Biggen, P. Deininger, P. Farrell, T. Gibson, G. Harful, G. Hudson, S. Satchwell, C. Sequin, P. Tuffnell, and B. Rarrell. 1984. DNA sequence and expression of the B95-8 Epstein-Barr virus. Nature (London) 310:207-211.
2. Bruckner, R., J. Crute, M. Dodson, and R. Lehman. 1991. The herpes simplex virus 1 origin binding protein: a DNA helicase. J. Biol. Chem. 266:2669-2674.
3. Buisson, M., E. Manet, M. C. Trescol-Biemont, H. Gruffat, B. Durand, and A. Sergeant 1989. The Epstein-Barr virus (EBV) early protein EB2 is a posttranscriptional activator expressed under control of EBV transcription factors EB1 and R. J. Virol. 63:5276-5284.
4. Chang, Y., D. Dong, G. Hayward, and S. D. Hayward. 1990 The Epstein-Barr virus Zta transactivator: a member of the bZIP family with unique DNA-binding specificity and a dimerization domain that lacks the characteristic heptad leucine zipper motif. J. Virol. 64:3358-3369.
5. Chavier, P., H. Gruffat, A. Chevallier-Greco, M. Buisson, and A. Sergeant. 1989. The Epstein-Barr (EBV) early promoter DR contains a cis-acting element responsive to the EBV trans-activator EB1 and an enhancer with constitutive and inducible activities. J. Virol. 63:607-613.
6. Chen, L.-W., L.-S. Lin, Y.-S. Chang, and S.-T. Liu. 1995. Functional analysis of EA-D of Epstein-Barr virus. Virology 211:593-597.
7. Chevallier-Greco, A., H. Gruffat, E. Manet, A. Calender, and A. Sergeant. 1989. The Epstein-Barr virus (EBV) DR enhancer contains two functionally different domains: domain A is constitutive and cell specific, domain B is transactivated by the EBV early protein R. J. Virol. 63:615-623.
8. Chevallier-Greco, A., E. Manet, P. Chavrier, C. Mosnier, J. Daillie, and A. Sergeant. 1986. Both Epstein-Barr virus (EBV) encoded trans-acting factors, EB1 and EB2, are required to activate transcription from an early EBV promoter. EMBO J. 5:3243-3249.
9. Chi, T., P. Lieberman, K. Ellwood, and M. Carey. 1995. A general mechanism for transcriptional synergy by eukaryotic activators. Nature (London) 377:254-257.
10. Chiou, J. F., J. K. Li, and Y. C. Cheng. 1985. Demonstration of a stimulatory protein for virus-specified DNA polymerase in phorbol ester-treated Epstein-Barr virus-carrying cells. Proc. Natl. Acad. Sci. USA 82:5728-5731.
11. Cho, M. S., G. Milman, and S. D. Hayward. 1985. A second Epstein-Barr virus early antigen gene in BamHI fragment M encodes a 48- to 50-kilodalton nuclear protein. J. Virol. 56:860-866.
12. Countryman, J., and G. Miller. 1985. Activation of expression of latent Epstein-Barr virus after gene transfer with a small cloned fragment of heterogeneous viral DNA. Proc. Natl. Acad. Sci. USA 82:4085-4089.
13. Cox, M., J. Leahy, and J. M. Hardwick. 1990. An enhancer within the divergent promoter of Epstein-Barr virus responds synergistically to the R and Z transactivators. J. Virol. 64:313-321.
14. Daibata, M., and T. Sairenji. 1993. Epstein-Barr virus (EBV) replication and expressions of EA-D (BMRF1 gene product), virus-specific deoxyribonucleotidase, and DNA polymerase in EBV-activated Akata cells. Virology 196: 900-904.
15. Dean, F., P. Bullock, Y. Murakami, C. Wobbe, L. Weissbach, and J. Hurwitz, 1987. Simian virus 40 (SV40) DNA replication: SV40 large T antigen unwinds DNA containing the SV40 origin of replication. Proc. Natl. Acad. Sci. USA 84:16-20.
16. DePamphilis, M. 1988. Transcriptional elements as components of eucaryotic origins of DNA replication. Cell 52:635-638.
17. Dornreiter, I., L. Erdile, I. Gilbert, D. von Winkler, T. Kelley, and E. Fanning. 1992. Interaction of DNA polymerase a-primase with cellular replication protein A and SV40 T antigen. EMBO J. 11:769-776.
18. Dorsky, D. Unpublished results.
19. Elias, P., M. O'Donnell, E. Mocarski, and I. R. Lehman. 1986. A DNA binding protein specific for an origin of replication of herpes simplex type 1. Proc. Natl. Acad. USA 83:6322-6326.
20. Farrell, P., D. Rowe, C. Rooney, and T. Kouzarides. 1989. Epslcin-Barr virus BZLF1 trans-activator specifically binds to consensus Ap 1 site and is related to c-fos. EMBO J. 8:127-132.
21. Fixman, E., G. Hayward, and S. D. Hayward. 1992. trans-acting requirements for replication of Epstein-Barr virus ori-Lyt. J. Virol. 66:5030-5039.
22. Fixman, E., G. Hayward, and S. D. Hayward. 1995. Replication of Epstein-Barr virus oriLyt: lack of a dedicated virally encoded origin-binding protein and dependence on Zta in cotransfection assays. J. Virol. 69:2998-3006.
23. Flemington, E., J. Lytle, C. Cayrol, A. Borras, and S. Speck. 1994. DNA-binding-defective mutants of the Epstein-Barr virus lytic switch activator ZTA transactivate with altered specificities. Mol. Cell. Biol. 14:3041-3052.
24. Flemington, E., and S. Speck. 1990. Autoregulation of Epstein-Barr virus putative lytic switch gene BZLF1. J. Virol. 64:1227-1232.
25. Flemington, E., and S. Speck. 1991. Evidence for coiled-coil dimer formation by an Epstein-Barr virus transactivator that lacks a heptad repeat of leucine residues. Proc. Natl. Acad. Sci. USA 87:9459-9463.
26. Frappier, L., and M. O'Donnell. 1992. EBNA-1 distorts oriP, the Epstein-Barr virus latent replication origin. J. Virol. 66:1786-1790.
27. Garner, M., and A. Revzin. 1981. A gel electrophoresis method for quantifying the binding of proteins to specific DNA regions: application to components of the Escherichia coli lactose operon regulatory system. Nucleic Acids Res. 9:3047-3060.
28. Glaser, R., and F. J. O'Neill. 1972. Hybridization of Burkitt lymphoblastoid cells. Science 176:1245-1247.
29. Gorman, C., L. Moffat, and B. Howard. 1982. Recombinant genomes which express chloramphenicol acetyl transferase in mammalian cells. Mol. Cell. Biol. 2:1044-1051.
30. Gottlieb, J., A. Marcy, D. Coen, and M. Challberg. 1990. The herpes simplex virus type 1 UL42 gene product: properties of the protein and evidence of its association with the virus-encoded polymerase. J. Virol. 64:5976-5987.
31. Guo, Z., and M. DePamphilis. 1992. Specific transcription factors stimulate transcription of simian virus 40 and polyomavirus origins of DNA replication. Mol. Cell. Biol. 12:2514-2524.
32. Gutsch, D., E. Holley-Guthrie, Q. Zhang, B. Stein, M. Blanar, A. Baldwin, and S. Kenney. 1994. The bZIP transactivator of Epstein-Barr virus. BZLF-1, functionally and physically interacts with the p65 subunit of NF-κB. Mol. Cell. Biol. 14:139-149.
33. Hammerschmidt, W., and B. Sugden. 1988. Identification and characterization of oriLyt, a lytic origin of replication of Epstein-Barr virus. Cell 55:427-433.
34. Holley-Guthrie, E., E. Quinlivan, E. Mar, and S. Kenney. 1990. The Epstein-Barr virus promoter for early antigen (EA-D) is regulated by the EBV transactivators, BRLF1 and BZLF1, in a cell specific manner. J. Virol. 64:3753-3759.
35. Kallin, B., L. Sternas, A. Saemundssen, J. Luka, H. Jornvall, B. Eriksson, P. Tao, T. Nilsson, and G. Klein. 1985. Purification of the Epstein-Barr virus DNA polymerase from P3HR-1 cells. J. Virol. 54:561-568.
36. Kenney, S., E. Holley-Guthrie, E. Quinlivan, D. Gutsch, Q. Zhang, T. Bender, J. Giot, and A. Sergeant. 1992. The cellular oncogene c-myb can interact synergistically with the Epstein-Barr virus BZLF1 transactivator in lymphoid cells. Mol. Cell. Biol. 12:136-146.
37. Kenney, S., J. Kamine, E. Holley-Guthrie, J. Lin, E. Mar, and J. Pagano. 1989. The Epstein-Barr virus (EBV) BZLF1 immediate-early gene product differentially affects latent versus productive EBV promoters. J. Virol. 63: 1729-1736.
38. Kieff, E., and D. Leibowitz. 1990. Epstein-Barr virus and its replication, p. 1889-1920. In B. Fields and D, Knipe (ed.), Virology, 2nd ed. Raven Press, New York.
39. Kiehl, A., and D. I. Dorsky. 1991. Cooperation of EBV DNA polymerise and EA-D (BMRF1) in vitro and colocalization in nuclei of infected cells. Virology 184:330-340.
40. Kiehl, A., and D. Dorsky. 1995. Bipartite DNA-binding region of the Epstein-Barr virus BMRF1 product essential for DNA polymerase accessory function. J. Virol. 69:1669-1677.
41. Kolman, J., N. Taylor, L. Gradoville, J. Countryman, and G. Miller. 1996. Comparing transcriptional activation and autostimulation by ZEBRA and ZEBRA/c-fos chimeras. J. Virol. 70:1493-1504.
42. Li, R., and M. Botchan. 1994. Acidic transcription factors alleviate nuclcosome-mediated repression of DNA replication of bovine papilloma virus type 1. Proc. Natl. Acad. Sci. USA 91:7051-7055.
43. Li, J. S., B. S. Zhou, G. E. Dutschman, S. P. Grill, R. S. Tan, and Y. C. Cheng. 1987. Association of Epstein-Barr virus early antigen diffuse component and virus-specified DNA polymerase activity. J. Virol. 61:2947-2949.
44. Lieherman, P., and A. Berk. 1990. In vitro transcriptional activation, dimerization, and DNA-binding specificity of the Epstein-Barr virus Zta protein. J. Virol. 64:2560-2568.
45. Luka, J., B. Kallin, and G. Klein. 1979. Induction of the Epstein-Barr virus cycle in latently infected cells by n-butyrate. Virology 94:228-231.
46. Miller, G. 1990. The Epstein-Barr virus, p. 1921-1957, In B. Fields, D. Knipe et al. (ed.), Virology. Raven Press, New York.
47. Mohr, I., R. Clark, S. Sun, E. Androphy, P. MacPherson, and M. Botchan. 1991. Targeting the E1 replication protein to the papillomavirus origin of replication by complex formation with the E2 transactivator. Science 250: 1694-1699.
48. Oguro, M., N. Shimizu, Y. Ono, and K. Takada. 1987. Both the rightward and the leftward open reading frames within the BamHI M DNA fragment of Epstein-Barr virus act as trans-activators of gene expression. J. Virol. 61:3310-3313.
49. Olivo, P., N. Nelson, and M. Chalberg. 1988. Herpes simplex virus DNA replication: the UL9 gene encodes an origin-binding protein. Proc. Natl. Acad. Sci. USA 85:5414-5418.
50. Pearson, G. R., B. Vroman, B. Chase, T. Sculley, M. Hummel, and E. Kieff. 1983. Identification of polypeptide components of the Epstein-Barr virus early antigen complex with monoclonal antibodies. J. Virol. 47:193-201.
51. Quinlivan, E., E. Holley-Guthrie, M. Norris, D. Gutsch, S. Bachenheimer, and S. Kenney. 1993. Direct BRLF1 binding is required for cooperative BZLF1/BRLF1 activation of the Epstein-Barr virus early promoter, BMRF1. Nucleic Acids Res. 21:1999-2007.
52. Raab-Traub, N., and K. Flynn. 1986. The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation. Cell 47:883-889.
53. Rooney, C., N. Taylor, J. Countryman, H. Jenson, J. Kolman, and G. Miller. 1988. Genome rearrangements activate the Epstein-Barr virus gene whose product disrupts latency. Proc. Natl. Acad. Sci. USA 85:9801-9805.
54. Sato, H., T. Takimoto, S. Tanaka, J. Yanaka, and N. Raab-Traub. 1990. Concatameric replication of Epstein-Barr virus: structure of the termini in virus-producer and newly transformed cell lines. J. Virol. 64:5295-5300.
55. Schepers, A., D. Pich, and W. Hammerschmidt. 1993. A transcription factor with homology to the Ap1 family links RNA transcription and DNA replication in the lytic cycle of Epstein-Barr virus. EMBOJ. 12:3921-3929.
56. Schepers, A., D. Pich, J. Mankertz, and W. Hammerschmidt. 1993. cis-acting elements in the lytic origin of DNA replication of Epstein-Barr virus. J. Virol. 67:4237-4245.
57. Sista, N., Barry, C., Sampson, K., and J. Pagano. 1995 Physical and functional interaction of the Epstein-Barr virus BZLF1 transactivator with the retinoic acid receptors RARa and RXRa. Nucleic Acids Res. 23:1729-1736.
58. Smith, D., and K. Johnson. 1987. Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. Gene 67:31-40.
59. Su, W., T. Middleton, B. Sugden, and H. Echols. 1991. DNA looping between the origin of replication of Epstein-Barr virus and its enhancer site: stabilization of an origin complex with Epstein-Barr nuclear antigen 1. Proc. Natl. Acad. Sci. USA 88:10870-10874.
60. Takada, K., and Y. Ono. 1989. Synchronous and sequential activation of latently infected Epstein-Barr virus genomes. J. Virol. 263:445-449.
61. Takada, K., N. Shimuzu, S. Sakuma, and A. Keating. 1986. Transactivation of the latent Epstein-Barr virus (EBV) genome after transfection of the EBV BamHI Z DNA fragment. J. Virol. 57:1011-1022.
62. Takagi, S., K. Takada, and T. Sairenji. 1991. Formation of intranuclear replication compartments of Epstein-Barr virus with redistribution of BZLF1 and BMRF1 gene products. Virology 185:309-315.
63. Tsurumi, T. 1993. Purification and characterization of the DNA-binding activity of the Epstein-Barr virus DNA polymerase accessory protein BMRF1 gene products, as expressed in insect cells by using the baculovirus system. J. Virol. 67:1681-1687.
64. Tsurumi, T., T. Daikoku, R. Kurachi. and Y. Nishiyama. 1993. Functional interaction between Epstein-Barr virus DNA polymerase catalytic subunit and its accessory subunit in vitro. J. Virol. 67:7648-7653.
65. Tsurumi, T., A. Kobayashi, K. Tamai, T. Daikoku, R. Kurachi, and Y. Nishiyama. 1993. Functional expression and characterization of the Epstein-Barr virus DNA polymerase catalytic subunit. J. Virol. 67:4651-4658.
66. Urier, G., Buisson, M., Chambar, P., and A. Sergeant. 1989. The Epstein-Barr virus early protein EB1 activates transcription from different responsive elements including ApI binding sites. EMBO J. 8:1447-1453.
67. Whyte, P., N. Williamson, and E. Harlow. 1989. Cellular targets for transformation by the adenovirus E1A proteins. Cell 56:67-75.
68. Wong, K.-M., and A. Levine. 1986. Identification and mapping of the Epstein-Barr virus early antigens and demonstration of a viral activator that functions in trans. J. Virol. 60:149-156.
69. Wong, S., and P. Schaffer. 1991. Elements in the transcriptional regulatory region flanking herpes simplex virus type 1 oriS stimulate origin function. J. Virol. 65:2601-2611.
70. Yang, L., I. Mohr, R. Clark, and M. Botchan. 1991. Activation of BPV-replication in vitro by transcription factor E2. Nature (London) 353:628-632.
71. Yang, L., I. Mohr, E. Fouts, D. Lim, M. Nohaile, and M. Botchan. 1993. The E1 protein of the papillomavirus BPV-1 is an ATP dependent DNA helicase. Proc. Natl. Acad. Sci. USA 90:5086-5090.
72. Young, L., R. Lau, M. Rowe, G. Niedobitek, G. Packham, F. Shanahan, D. Rowe, D. Greenspan, J. Greenspan, A. Rickinson, and P. Farrell. 1991. Differentiation-associated expression of the Epstein-Barr virus BZLFI transactivator in oral hairy leukoplakia. J. Virol. 65:2868-2874.
73. Zalani, S., E. Holley-Guthrie, and S. Kenney. Epstein-Barr viral latency is disrupted by the immediate-early BRLF1 protein through a cell-specific mechanism. Proc. Natl. Acad. Sci. USA, in press.
74. Zhang, Q., D. Gutsch, and S. Kenney. 1994. Functional and physical interaction between p53 and BZLF1: implications for Epstein-Barr virus latency. Mol. Cell. Biol. 14:1929-1938.
75. Zur Hausen, H., G. Bornkamm, R. Schmidt, and E. Hecker. 1979. Tumor initiators and promoters in the induction of Epstein-Barr virus. Proc. Natl. Acad. Sci. USA 76:782-785.
76. Zur Hausen, H., H. Schulte-Holthauzen, G. Klein, G. Henle, W. Henle, P. Clifford, and L. Santesson. 1970. EBV DNA in biopsies of Burkitt tumours and anaplastic carcinomas of the nasopharynx. Nature (London) 228:1956-1958.